A rare genetic disorder left an infant with debilitating seizures and developmental delays. The medicines weren't working, but the family and their team of doctors at Stanford Children's Health, including Dr. Brenda Porter and Dr. Gerald Grant, refused to give up hope.
Bereaved mother Mycah Clemons raised money for a summer scholarship at Stanford for research on diffuse intrinsic pontine glioma. The move sparked a series of experiments that have led to a possible treatment for the tumor.
Gracin Hahne was just an infant when she experienced her first seizure, caused by benign tumors - called tubors - in her brain. By the time she was 3 years old, the seizures had gotten out of control, no longer responding to medication and significantly affecting her cognitive development. Her medical team at Stanford used an innovative procedure using a robot to remove the tubors and eliminate the cause of Gracin's seizures for good.
Slated to welcome its first patients on December 9, the building more than doubles the size of the existing hospital. The existing facility, now renamed the “West” building, will remain open and undergo remodeling over the next few years, while the new “Main” building will provide 521,000 square feet of new space, 3.5 acres of healing gardens and 149 patient beds
Michelle Monje, assistant professor of neurology and neurological sciences, authored a new study that provides a better understanding why diffuse intrinsic pontine glioma, a rare, aggressive brain cancer found in children, metastasizes quickly to a specific part of the brain. The findings could help the advancement of drugs to treat the disease.
The pediatric and obstetric centers of the Lucile Packard Children’s Hospital Stanford will debut in December, opening its doors to children and expectant mothers at new facilities that more than double the existing campus.
More than doubling its current size, the expanded Lucile Packard Children’s Hospital Stanford will transform the patient experience through family-centered design and technological innovation, while setting new standards for sustainability in hospital design.
The Stanford University School of Medicine has more students graduating who go into neurology than any other medical school in the country. And largely, they’re going into child neurology. It’s a success that speaks a synergy of education, innovation, science and care that is unique to Stanford.
After Dylan’s death on Jan. 8, 2009, Monje and her colleagues transformed his tumor into the first cell culture of its type anywhere in the world. A few months later, a story in Stanford Medicine magazine about the Jewetts’ gift inspired more families to make similar donations, further boosting the research.
Medical attire innovator Medelita has named Dr. Jonathan Santoro winner of the 2015 The Right Fit H.E.R.O. Honorarium. Dr. Santoro's candidacy was among 200 nominations of medical residents throughout the United States.
New research shows that high-grade gliomas, the deadliest human brain tumors, increase their growth by hijacking some of the machinery of neuroplasticity, which normally helps the brain form new synapses.
This blog highlights a California Institute for Regenerative Medicine video featuring Michelle Monje, assistant professor of neurology, in which she explains the effects of cancer treatment on the brain.
This Is Your Brain on Chemo / Cell, January 10, 2019